This phenomenon of co-localising chr8:ZNF703/FGFR1 and chr11:CCND1 amplicons tends to be seen in ER-positive tumours, among patients diagnosed at an older age (Figure 4). This evidence concerns the gene FGFR1 and neoplasm.